| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date |
|---|
| Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma | [1]Ajay K Nooka, [2]Uma Shanmugasundaram, [3]Narayana Cheedarla, [4]Hans Verkerke, [5]Venkata Viswanadh Edara, [6]Rajesh Valanparambil, [7]Jonathan L Kaufman, [8]Craig C Hofmeister, [9]Nisha S Joseph, [10]Sagar Lonial, ... [Full author list] | Journal of Clinical Oncology [curation] | DOI: 10.1200/JCO.21.02257
| | 2022-09-10 |
| Venetoclax ex vivo functional profiling predicts improved progression-free survival | [1]Vikas Gupta, [2]Shannon M. Matulis, [3]Benjamin G Barwick, [4]R. Devin Bog, [5]Conrad W. Shebelut, [6]Mala Shanmugam, [7]Paola Neri, [8]Nizar J. Bahlis, [9]Madhav Dhodapkar, [10]Leonard T. Heffner, [11]Craig C Hofmeister, [12]Nisha S. Joseph, [13]Sagar Lonial, [14]Jonathan L Kaufman, [15]David L. Jaye, [16]Ajay K Nooka, [17]Lawrence H Boise [Full author list] | Blood Cancer Journal [curation] | DOI: 10.1038/S41408-022-00710-9
| | 2022-08-01 |
| Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | [1]Roberto Mina, [2]Nisha S Joseph, [3]Francesca Gay, [4]Efstathios Kastritis, [5]Maria Teresa Petrucci, [6]Jonathan L Kaufman, [7]Vittorio Montefusco, [8]Maria Gavriatopoulou, [9]Francesca Patriarca, [10]Paola Omedé, ..., [20]Sagar Lonial, [21]Mario Boccadoro, [22]Ajay K Nooka, [23]Athanasios Dimopoulos [Full author list] | Blood Cancer Journal [curation] | DOI: 10.1038/S41408-020-0307-4
PubMed: 32286263 | | 2020-04-14 |
| Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma | [1]Richa Bajpai, [2]Aditi Sharma, [3]Abhinav Achreja, [4]Claudia L Edgar, [5]Changyong Wei, [6]Arusha A Siddiqa, [7]Vikas A Gupta, [8]Shannon M Matulis, [9]Samuel K McBrayer, [10]Anjali Mittal, [11]Manali Rupji, [12]Benjamin G Barwick, [13]Sagar Lonial, [14]Ajay K Nooka, [15]Lawrence H Boise, [16]Deepak Nagrath, [17]Mala Shanmugam [Full author list] | Nature Communications [curation] | DOI: 10.1038/S41467-020-15051-Z
PubMed: 32144272 | | 2020-03-06 |
| Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | [1]Maria Gavriatopoulou, [2]Ajai Chari, [3]Christine Chen, [4]Nizar Bahlis, [5]Dan T Vogl, [6]Andrzej Jakubowiak, [7]David Dingli, [8]Robert F Cornell, [9]Craig C Hofmeister, [10]David Siegel, ..., [17]Sundar Jagannath, [18]Rachid Baz, [19]Ajay K Nooka, [20]Joshua Richter, [21]Rafat Abonour, ... [Full author list] | Leukemia [curation] | DOI: 10.1038/S41375-020-0756-6
PubMed: 32094461 | | 2020-02-24 |
| Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study | [1]Sagar Lonial, [2]Hans C Lee, [3]Ashraf Z Badros, [4]Suzanne Trudel, [5]Ajay K Nooka, [6]Ajai Chari, [7]Al-Ola Abdallah, [8]Natalie Callander, [9]Nikoletta Lendvai, [10]Douglas Sborov, ... [Full author list] | Lancet Oncology Commission [curation] | DOI: 10.1016/S1470-2045(19)30788-0
PubMed: 31859245 | | 2019-12-16 |
| Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma | [1]Ajai Chari, [2]Dan T Vogl, [3]Maria Gavriatopoulou, [4]Ajay K Nooka, [5]Andrew J Yee, [6]Carol A Huff, [7]Philippe Moreau, [8]David Dingli, [9]Craig Cole, [10]Sagar Lonial, ... [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJMOA1903455
PubMed: 31433920 | dexamethasone [curation] | 2019-08-01 |
| Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients | [1]Ajay K Nooka, [2]Nisha S Joseph, [3]Jonathan L Kaufman, [4]Leonard T Heffner, [5]Vikas Gupta, [6]Charise Gleason, [7]Lawrence H Boise, [8]Sagar Lonial [Full author list] | Cancer [curation] | DOI: 10.1002/CNCR.32178
PubMed: 31090928 | dexamethasone [curation] | 2019-05-15 |
| Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy | [1]Jithendra Kini Bailur, [2]Samuel S McCachren, [3]Deon B Doxie, [4]Mahesh Shrestha, [5]Katherine Pendleton, [6]Ajay K Nooka, [7]Natalia Neparidze, [8]Terri L Parker, [9]Noffar Bar, [10]Jonathan L Kaufman, [11]Craig C Hofmeister, [12]Lawrence H Boise, [13]Sagar Lonial, [14]Melissa L Kemp, [15]Kavita M Dhodapkar, [16]Madhav V Dhodapkar [Full author list] | JCI insight [curation] | DOI: 10.1172/JCI.INSIGHT.127807
PubMed: 31013254 | | 2019-04-23 |
| Daratumumab in multiple myeloma | [1]Ajay K Nooka, [2]Jonathan L Kaufman, [3]Craig C Hofmeister, [4]Nisha S Joseph, [5]Thomas L Heffner, [6]Vikas A Gupta, [7]Harold C Sullivan, [8]Andrew S Neish, [9]Madhav V Dhodapkar, [10]Sagar Lonial [Full author list] | Cancer [curation] | DOI: 10.1002/CNCR.32065
PubMed: 30951198 | | 2019-04-05 |
| Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whites | [1]Sarah Chehab, [2]Chao Zhang, [3]Elyse H Panjic, [4]Zhengjia Chen, [5]Jonathan L Kaufman, [6]Sagar Lonial, [7]Ajay K Nooka, [8]R Donald Harvey [Full author list] | Cancer [curation] | DOI: 10.1002/CNCR.31746
PubMed: 30303526 | multiple myeloma [curation] | 2018-10-10 |
| Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital | [1]Hyun D Yun, [2]Tehseen Dossul, [3]Leon Bernal-Mizrachi, [4]Jeffrey M Switchenko, [5]Chukwuma Ndibe, [6]Abiola Ibraheem, [7]Margie D Dixon, [8]Amelia A Langston, [9]Ajay K Nooka, [10]Christopher R Flowers, [11]Rebecca D. Pentz, [12]Edmund K Waller [Full author list] | Journal of stem cell research & therapy [curation] | DOI: 10.4172/2157-7633.1000328
PubMed: 28966870 | | 2016-02-19 |
| Treatment options for relapsed and refractory multiple myeloma | [1]Ajay K Nooka, [2]Efstathios Kastritis, [3]Athanasios Dimopoulos, [4]Sagar Lonial [Full author list] | Blood [curation] | DOI: 10.1182/BLOOD-2014-11-568923
PubMed: 25838342 | | 2015-04-02 |
| Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data | [1]Antonio Palumbo, [2]Sara Bringhen, [3]Shaji K Kumar, [4]Giulia Lupparelli, [5]Saad Z Usmani, [6]Anders Waage, [7]Alessandra Larocca, [8]Bronno van der Holt, [9]Pellegrino Musto, [10]Massimo Offidani, ..., [12]Débora Andréa Evangelista Façanha, [13]Sonja Zweegman, [14]Ajay K Nooka, [15]Andrew Spencer, [16]Athanasios Dimopoulos, ... [Full author list] | Lancet Oncology Commission [curation] | DOI: 10.1016/S1470-2045(13)70609-0
PubMed: 24525202 | patient [curation]; meta-analysis [curation] | 2014-02-11 |
| Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study | [1]Yasser H Shaib, [2]Hashem El-Serag, [3]Ajay K Nooka, [4]Melanie B Thomas, [5]Thomas D Brown, [6]Yehuda Patt, [7]Manal Hassan [Full author list] | The American Journal of Gastroenterology [curation] | DOI: 10.1111/J.1572-0241.2007.01104.X
PubMed: 17324130 | cholangiocarcinoma [curation] | 2007-02-23 |
| Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial | [1]Yehuda Patt, [2]Manal Hassan, [3]Richard D Lozano, [4]Ajay K Nooka, [5]Isaac I Schnirer, [6]Jerome B Zeldis, [7]James Lewis Abbruzzese, [8]Thomas D Brown [Full author list] | Cancer [curation] | DOI: 10.1002/CNCR.20821
PubMed: 15660400 | patient [curation]; thalidomide [curation]; hepatocellular carcinoma [curation]; phase II clinical trial [curation] | 2005-02-01 |
| Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma | [1]Yehuda Patt, [2]Manal Hassan, [3]Alvaro Aguayo, [4]Ajay K Nooka, [5]Richard D Lozano, [6]Steven A Curley, [7]Jean-Nicolas Vauthey, [8]Lee M Ellis, [9]Isac I Schnirer, [10]Robert A Wolff, [11]Chusilp Charnsangavej, [12]Thomas D Brown [Full author list] | Cancer [curation] | DOI: 10.1002/CNCR.20368
PubMed: 15274071 | cholangiocarcinoma [curation]; capecitabine [curation]; hepatocellular carcinoma [curation]; gallbladder carcinoma [curation] | 2004-08-01 |